These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. In vitro fabrication of a tissue engineered human cardiovascular patch for future use in cardiovascular surgery. Yang C; Sodian R; Fu P; Lüders C; Lemke T; Du J; Hübler M; Weng Y; Meyer R; Hetzer R Ann Thorac Surg; 2006 Jan; 81(1):57-63. PubMed ID: 16368335 [TBL] [Abstract][Full Text] [Related]
23. Tissue engineering of cardiac valves: re-seeding of acellular porcine aortic valve matrices with human mesenchymal progenitor cells. Knight RL; Booth C; Wilcox HE; Fisher J; Ingham E J Heart Valve Dis; 2005 Nov; 14(6):806-13. PubMed ID: 16359063 [TBL] [Abstract][Full Text] [Related]
24. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates? Vincentelli A; Wautot F; Juthier F; Fouquet O; Corseaux D; Marechaux S; Le Tourneau T; Fabre O; Susen S; Van Belle E; Mouquet F; Decoene C; Prat A; Jude B J Thorac Cardiovasc Surg; 2007 Aug; 134(2):424-32. PubMed ID: 17662783 [TBL] [Abstract][Full Text] [Related]
27. Fabrication of a novel hybrid heart valve leaflet for tissue engineering: an in vitro study. Hong H; Dong N; Shi J; Chen S; Guo C; Hu P; Qi H Artif Organs; 2009 Jul; 33(7):554-8. PubMed ID: 19566733 [TBL] [Abstract][Full Text] [Related]
28. Construction of autologous human heart valves based on an acellular allograft matrix. Cebotari S; Mertsching H; Kallenbach K; Kostin S; Repin O; Batrinac A; Kleczka C; Ciubotaru A; Haverich A Circulation; 2002 Sep; 106(12 Suppl 1):I63-I68. PubMed ID: 12354711 [TBL] [Abstract][Full Text] [Related]
29. Cholesterol-modified polyurethane valve cusps demonstrate blood outgrowth endothelial cell adhesion post-seeding in vitro and in vivo. Stachelek SJ; Alferiev I; Connolly JM; Sacks M; Hebbel RP; Bianco R; Levy RJ Ann Thorac Surg; 2006 Jan; 81(1):47-55. PubMed ID: 16368333 [TBL] [Abstract][Full Text] [Related]
30. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Shinoka T; Ma PX; Shum-Tim D; Breuer CK; Cusick RA; Zund G; Langer R; Vacanti JP; Mayer JE Circulation; 1996 Nov; 94(9 Suppl):II164-8. PubMed ID: 8901739 [TBL] [Abstract][Full Text] [Related]
31. Development of an in vivo tissue-engineered, autologous heart valve (the biovalve): preparation of a prototype model. Hayashida K; Kanda K; Yaku H; Ando J; Nakayama Y J Thorac Cardiovasc Surg; 2007 Jul; 134(1):152-9. PubMed ID: 17599501 [TBL] [Abstract][Full Text] [Related]
32. [A xenogeneic acellularized matrix for heart valve tissue engineering: in vivo study in a sheep model]. Leyh R; Wilhelmi M; Haverich A; Mertsching H Z Kardiol; 2003 Nov; 92(11):938-46. PubMed ID: 14634763 [TBL] [Abstract][Full Text] [Related]
33. Fabrication of biomatrix/polymer hybrid scaffold for heart valve tissue engineering in vitro. Hong H; Dong GN; Shi WJ; Chen S; Guo C; Hu P ASAIO J; 2008; 54(6):627-32. PubMed ID: 19033778 [TBL] [Abstract][Full Text] [Related]
34. The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds. Iop L; Renier V; Naso F; Piccoli M; Bonetti A; Gandaglia A; Pozzobon M; Paolin A; Ortolani F; Marchini M; Spina M; De Coppi P; Sartore S; Gerosa G Biomaterials; 2009 Sep; 30(25):4104-16. PubMed ID: 19481252 [TBL] [Abstract][Full Text] [Related]
35. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Engelmayr GC; Rabkin E; Sutherland FW; Schoen FJ; Mayer JE; Sacks MS Biomaterials; 2005 Jan; 26(2):175-87. PubMed ID: 15207464 [TBL] [Abstract][Full Text] [Related]
36. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling. Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720 [TBL] [Abstract][Full Text] [Related]
38. Use of human umbilical cord blood-derived progenitor cells for tissue-engineered heart valves. Sodian R; Schaefermeier P; Abegg-Zips S; Kuebler WM; Shakibaei M; Daebritz S; Ziegelmueller J; Schmitz C; Reichart B Ann Thorac Surg; 2010 Mar; 89(3):819-28. PubMed ID: 20172137 [TBL] [Abstract][Full Text] [Related]
39. Tissue engineering technologies: just a quick note about transplantation of bioengineered donor trachea and augmentation cystoplasty by de novo engineered bladder tissue. Alberti C G Chir; 2009; 30(11-12):514-9. PubMed ID: 20109384 [TBL] [Abstract][Full Text] [Related]